{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:47:31Z","timestamp":1790059651907,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.steroids.2014.08.009","type":"journal-article","created":{"date-parts":[[2014,8,24]],"date-time":"2014-08-24T08:15:59Z","timestamp":1408868159000},"page":"39-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"PA","title":["Estradiol assays \u2013 The path ahead"],"prefix":"10.1016","volume":"99","author":[{"given":"Hemamalini","family":"Ketha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Girtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder J.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2014.08.009_b0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0960-0760(03)00360-1","article-title":"Sources of estrogen and their importance","volume":"86","author":"Simpson","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2014.08.009_b0010","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1210\/jc.2012-3780","article-title":"Challenges to the measurement of estradiol: an endocrine society position statement","volume":"98","author":"Rosner","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.08.009_b0015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1210\/jc.2013-2905","article-title":"Measurement of estradiol-challenges ahead","volume":"99","author":"Stanczyk","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.08.009_b0020","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/jnci\/91.4.380","article-title":"Re: plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women","volume":"91","author":"Dorgan","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.steroids.2014.08.009_b0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/jnci\/88.5.291","article-title":"Serum sex hormone levels after menopause and subsequent breast cancer","volume":"88","author":"Berrino","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.steroids.2014.08.009_b0030","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/jnci\/87.3.190","article-title":"A prospective study of endogenous estrogens and breast cancer in postmenopausal women","volume":"87","author":"Toniolo","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.steroids.2014.08.009_b0035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.bjc.6601517","article-title":"Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study","volume":"90","author":"Zeleniuch-Jacquotte","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.steroids.2014.08.009_b0040","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.steroids.2007.05.003","article-title":"Superiority of gas chromatography\/tandem mass spectrometry assay (GC\/MS\/MS) for estradiol for monitoring of aromatase inhibitor therapy","volume":"72","author":"Santen","year":"2007","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2014.08.009_b0045","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1158\/1055-9965.EPI-10-0081","article-title":"Limitations of direct immunoassays for measuring circulating estradiol levels in postmenopausal women and men in epidemiologic studies","volume":"19","author":"Stanczyk","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.steroids.2014.08.009_b0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MED.0000000000000068","article-title":"Clinical applications of LC\u2013MS sex steroid assays: evolution of methodologies in the 21st century","volume":"21","author":"Ketha","year":"2014","journal-title":"Curr Opin Endocrinol Diab Obes"},{"key":"10.1016\/j.steroids.2014.08.009_b0055","first-page":"201","article-title":"Precision and long-term stability of different estradiol immunoassays assessed in a multi-center quality control study","volume":"55","author":"Reinsberg","year":"2009","journal-title":"Clin Lab"},{"key":"10.1016\/j.steroids.2014.08.009_b0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.steroids.2013.12.005","article-title":"High variability in serum estradiol measurements in men and women","volume":"82","author":"Vesper","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2014.08.009_b0065","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2193-1801-2-5","article-title":"Deficiencies in immunoassay methods used to monitor serum Estradiol levels during aromatase inhibitor treatment in postmenopausal breast cancer patients","volume":"2","author":"Jaque","year":"2013","journal-title":"Springerplus"},{"key":"10.1016\/j.steroids.2014.08.009_b0070","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/clinchem\/34.5.949","article-title":"Six direct radioimmunoassays of estradiol evaluated","volume":"34","author":"Schioler","year":"1988","journal-title":"Clin Chem"},{"key":"10.1016\/j.steroids.2014.08.009_b0075","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0021-9673(99)00153-3","article-title":"Clinical applications of gas chromatography and gas chromatography\u2013mass spectrometry of steroids","volume":"843","author":"Wolthers","year":"1999","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.steroids.2014.08.009_b0080","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/clinchem\/34.10.2066","article-title":"Estradiol-17 beta quantified in serum by isotope dilution-gas chromatography\u2013mass spectrometry: reversed-phase C18 high-performance liquid chromatography compared with immuno-affinity chromatography for sample pretreatment","volume":"34","author":"Thienpont","year":"1988","journal-title":"Clin Chem"},{"key":"10.1016\/j.steroids.2014.08.009_b0085","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1309\/LC03BHQ5XJPJYEKG","article-title":"High-sensitivity tandem mass spectrometry assay for serum estrone and estradiol","volume":"129","author":"Kushnir","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.steroids.2014.08.009_b0090","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1373\/clinchem.2003.025478","article-title":"Liquid chromatography\u2013tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma","volume":"50","author":"Nelson","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.steroids.2014.08.009_b0095","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.clinbiochem.2008.02.009","article-title":"Rapid measurement of estrogens and their metabolites in human serum by liquid chromatography\u2013tandem mass spectrometry without derivatization","volume":"41","author":"Guo","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1016\/j.steroids.2014.08.009_b0100","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1373\/clinchem.2007.100008","article-title":"Steroid hormone analysis by tandem mass spectrometry","volume":"55","author":"Soldin","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.steroids.2014.08.009_b0105","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1210\/jc.2013-1677","article-title":"Postnatal ovarian activation has effects in estrogen target tissues in infant girls","volume":"98","author":"Kuiri-Hanninen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.08.009_b0110","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1210\/jc.2012-4243","article-title":"Metabolic effects of oral versus transdermal 17beta-estradiol (E(2)): a randomized clinical trial in girls with Turner syndrome","volume":"98","author":"Torres-Santiago","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.08.009_b0115","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1172\/JCI104130","article-title":"Immunoassay of endogenous plasma insulin in man","volume":"39","author":"Yalow","year":"1960","journal-title":"J Clin Invest"},{"key":"10.1016\/j.steroids.2014.08.009_b0120","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1210\/jcem-29-6-866","article-title":"Solid-phase radioimmunoassay of estradiol-17 beta","volume":"29","author":"Abraham","year":"1969","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.08.009_b0125","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1373\/clinchem.2013.213363","article-title":"Performance of direct estradiol immunoassays with human male serum samples","volume":"60","author":"Handelsman","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.steroids.2014.08.009_b0130","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa032312","article-title":"A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer","volume":"349","author":"Goss","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2014.08.009_b0135","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1093\/annonc\/mdg362","article-title":"Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer","volume":"14","author":"Paridaens","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.steroids.2014.08.009_b0140","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1158\/1078-0432.CCR-04-2187","article-title":"Aromatase inhibition: translation into a successful therapeutic approach","volume":"11","author":"Geisler","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.steroids.2014.08.009_b0145","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jsbmb.2007.12.011","article-title":"An optimised, highly sensitive radioimmunoassay for the simultaneous measurement of estrone, estradiol and estrone sulfate in the ultra-low range in human plasma samples","volume":"109","author":"Geisler","year":"2008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2014.08.009_b0150","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.beem.2013.05.015","article-title":"Novel liquid chromatography tandem mass spectrometry (LC\u2013MS\/MS) methods for measuring steroids","volume":"27","author":"Keevil","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.08.009_b0155","doi-asserted-by":"crossref","first-page":"10245","DOI":"10.1021\/ac301984t","article-title":"Comprehensive and highly sensitive urinary steroid hormone profiling method based on stable isotope-labeling liquid chromatography\u2013mass spectrometry","volume":"84","author":"Dai","year":"2012","journal-title":"Anal Chem"},{"key":"10.1016\/j.steroids.2014.08.009_b0160","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5858\/2004-128-469-SPULCM","article-title":"Steroid profiles using liquid chromatography\u2013tandem mass spectrometry with atmospheric pressure photoionization source","volume":"128","author":"Guo","year":"2004","journal-title":"Arch Pathol Lab Med"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X14002025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X14002025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T08:32:54Z","timestamp":1650011574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X14002025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":32,"alternative-id":["S0039128X14002025"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2014.08.009","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estradiol assays \u2013 The path ahead","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2014.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}